论文部分内容阅读
目的评价膀胱移行细胞癌(transitional cell carcinoma,TCC)合并前列腺增生采取同期经尿道电切治疗的疗效。方法将患者分为A、B两组,A组25例实施单纯经尿道电切膀胱移行细胞癌,B组20例实施经尿道同期电切膀胱移行细胞癌及增生的前列腺,比较术后A、B两组间复发率、进展率、复发时间、膀胱颈部及前列腺窝复发率的差异。结论所有患者随访12～48个月,平均随访25.4个月。A、B两组术后肿瘤复发率、复发时间、进展率、膀胱颈部及前列腺窝复发率的比较差异无统计学意义(P>0.05)。结论膀胱移行细胞癌合并前列腺增生实施同期经尿道电切术是可行的,与单纯电切膀胱移行细胞癌相比并不增加肿瘤的复发。
Objective To evaluate the efficacy of concurrent transurethral resection of transitional cell carcinoma (TCC) combined with benign prostatic hyperplasia (BPH). Methods The patients were divided into A and B groups, 25 cases in group A were treated with transurethral resection of bladder transitional cell carcinoma by transurethral resection alone, 20 cases in group B with transurethral resection of bladder transitional cell carcinoma and hyperplasia prostate, B recurrence rate, progression rate, recurrence time, bladder neck and prostate fossa recurrence rate difference. Conclusions All patients were followed up for 12-48 months with a mean follow-up of 25.4 months. There was no significant difference in recurrence rate, recurrence time, progression rate, recurrence rate of bladder neck and prostate gland between groups A and B (P> 0.05). Conclusions Transurethral resection of transitional cell carcinoma of the bladder combined with benign prostatic hyperplasia is feasible and does not increase the recurrence of tumors compared with that of purely resected bladder transitional cell carcinoma.